TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
208,223
|
222,130
|
200,431 |
| Financial expenses |
271
|
289
|
231 |
| Earnings before taxes |
8,363
|
14,586
|
15,458 |
| EBITDA |
7,805
|
14,296
|
15,600 |
| Total assets |
79,763
|
80,873
|
65,626 |
| Current assets |
79,387
|
80,485
|
65,186 |
| Current liabilities |
24,774
|
31,182
|
24,608 |
| Equity capital |
51,559
|
46,440
|
35,126 |
| - share capital |
69
|
71
|
67 |
| Employees (average) |
204
|
227
|
197 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
64.6%
|
57.4%
|
53.5% |
| Turnover per employee |
1,021
|
979
|
1,017 |
| Profit as a percentage of turnover |
4.0%
|
6.6%
|
7.7% |
| Return on assets (ROA) |
10.8%
|
18.4%
|
23.9% |
| Current ratio |
320.4%
|
258.1%
|
264.9% |
| Return on equity (ROE) |
16.2%
|
31.4%
|
44.0% |
| Change turnover |
-6,560
|
20,667
|
62,341 |
| Change turnover % |
-3%
|
10%
|
45% |
| Chg. No. of employees |
-23
|
30
|
51 |
| Chg. No. of employees % |
-10%
|
15%
|
35% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.